Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018¿2024) Nahum Méndez-Sánchez; Mariana M. Ramírez-Mejía; Carlos Cortez-Hernández; Elianee M. Tovar-Bojorquez; Raúl Contreras-Omaña; Juan D. Monsiváis-Morales; Jacqueline Cordova-Gallardo; Mauricio Castillo-Barradas; Nubia Guzmán-Rodríguez; María S. González-Huezo; Adrian Sandez-Araiza; Eira Cerda-Reyes; Stefanny Cornejo-Hernández; Beatriz Barranco-Fragoso; Ana D. Cano-Contreras; José M. Remes-Troche; Fatima Higuera-de-la-Tijera; José L. Pérez-Hernández; Norberto Chávez-Tapia; Francisco J. Valentin-Cortez; Iaarah Montalvo-Gordon; Rubén R. Lozano-Salazar; Montserrat Sabanes-Hernández; Itziar Borbolla-Schega; Heriberto Rodríguez-Hernández;

From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Federico Piñero; Ezequiel Mauro; Paola Casciato; Alejandro Forner;

Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;